-
公开(公告)号:US20110053929A1
公开(公告)日:2011-03-03
申请号:US12668633
申请日:2008-06-28
申请人: Stephan Siegel , Andreas Wilman , Susanne Röhrig , Niels Svenstrup , Mark Jean Gnoth , Stefan Heitmeier , Ulrich Rester , Adrian Tersteegen , Michael Gerisch
发明人: Stephan Siegel , Andreas Wilman , Susanne Röhrig , Niels Svenstrup , Mark Jean Gnoth , Stefan Heitmeier , Ulrich Rester , Adrian Tersteegen , Michael Gerisch
IPC分类号: A61K31/4985 , C07D487/04 , A61K31/5377 , A61P7/00 , C12N5/0789
CPC分类号: C07D487/04 , C12N5/0647
摘要: The invention relates to substituted imidazo-, pyrazolopyrazines and imidazotriazines and processes for their preparation, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, in particular of hematological disorders, preferably of leukopenias and neutropenias.
摘要翻译: 本发明涉及取代的咪唑并,吡唑并吡嗪和咪唑并嗪及其制备方法,以及它们用于制备用于治疗和/或预防疾病,特别是血液病症,优选白细胞减少症和中性粒细胞减少症的药物的用途。